Virtual screening in lead discovery and optimization.

scientific article published in July 2004

Virtual screening in lead discovery and optimization. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID15338948

P2093author name stringAjay N Jain
P433issue4
P921main subjectvirtual screeningQ4112105
P304page(s)396-403
P577publication date2004-07-01
P13046publication type of scholarly workreview articleQ7318358
P1433published inCurrent Opinion in Drug Discovery and DevelopmentQ15724606
P1476titleVirtual screening in lead discovery and optimization
P478volume7

Reverse relations

cites work (P2860)
Q36057399A Multimodal Data Analysis Approach for Targeted Drug Discovery Involving Topological Data Analysis (TDA).
Q27902353A graph-based approach to construct target-focused libraries for virtual screening
Q22309806A small-molecule dengue virus entry inhibitor
Q33484416A statistical framework to evaluate virtual screening
Q39842778Adapting Document Similarity Measures for Ligand-Based Virtual Screening.
Q42639520Bias, reporting, and sharing: computational evaluations of docking methods
Q47396500Combining in vitro and in silico approaches to find new drugs targeting the pathological proteins related to the Alzheimer's disease
Q30393891Comprehensive Structural and Functional Characterization of the Human Kinome by Protein Structure Modeling and Ligand Virtual Screening
Q36477542Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach
Q35921636Design of protein membrane interaction inhibitors by virtual ligand screening, proof of concept with the C2 domain of factor V
Q33543849Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of Dengue virus NS2B-NS3 protease
Q34304133Development of a Comprehensive, Validated Pharmacophore Hypothesis for Anthrax Toxin Lethal Factor (LF) Inhibitors Using Genetic Algorithms, Pareto Scoring, and Structural Biology
Q39786919Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse Agonists
Q35141761Discovery of benzamide analogs as negative allosteric modulators of human neuronal nicotinic receptors: pharmacophore modeling and structure-activity relationship studies.
Q30489011Docking Screens for Novel Ligands Conferring New Biology
Q42701435Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology
Q34908421Emerging methods for ensemble-based virtual screening
Q42553799FAF-Drugs: free ADME/tox filtering of compound collections.
Q36253308Identification of Novel Anthrax Toxin Countermeasures Using In Silico Methods
Q30478430Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening
Q34358658In silico discovery of potential VEGFR-2 inhibitors from natural derivatives for anti-angiogenesis therapy.
Q33893108Integrating Structure-Based and Ligand-Based Approaches for Computational Drug Design
Q38168995Ionic channels as targets for drug design: a review on computational methods
Q24813590MEDock: a web server for efficient prediction of ligand binding sites based on a novel optimization algorithm
Q35733861Molecular recognition in the case of flexible targets
Q61399225Multiple-step virtual screening using VSM-G: overview and validation of fast geometrical matching enrichment
Q36457138Mutation adjacent to the active site tyrosine can enhance DNA cleavage and cell killing by the TOPRIM Gly to Ser mutant of bacterial topoisomerase I.
Q30381629Q-Dock(LHM): Low-resolution refinement for ligand comparative modeling.
Q89208049Quantitative surface field analysis: learning causal models to predict ligand binding affinity and pose
Q35529977Small-molecule inhibitors of JC polyomavirus infection
Q36243872Statistical analysis, optimization, and prioritization of virtual screening parameters for zinc enzymes including the anthrax toxin lethal factor
Q36416631Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery
Q33519129Structural conservation in band 4.1, ezrin, radixin, moesin (FERM) domains as a guide to identify inhibitors of the proline-rich tyrosine kinase 2.
Q42992194Structure-based virtual screening for novel inhibitors of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase
Q33244012Successful computer guided planned synthesis of (4R)-thiazolidine carboxylic acid and its 2-substituted analogues as urease inhibitors.
Q46358770Surflex-Dock 2.1: robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search
Q33894613Tetrahydronaphthyridine and dihydronaphthyridinone ethers as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu₅).
Q33560594Total synthesis and evaluation of C26-hydroxyepothilone D derivatives for photoaffinity labeling of beta-tubulin.
Q33247681Virtual ligand screening: strategies, perspectives and limitations
Q28543048eMatchSite: sequence order-independent structure alignments of ligand binding pockets in protein models

Search more.